Contact Info

IFF
Alakiventie 2,
00920 Helsinki, Finland
Phone: +358-9 454 214 25
Fax: +358-9 454 214 50
E-mail: office(at)floorball.org

Events Calendar

May 2013
mon tue wed thu fri sat sun
  12345
67
8
9
10
11
12
13141516171819
20212223242526
2728293031  

See all events for 2013

Find IFF on:
IFF Events Mobile App
Flickr
YouTube
Facebook
Twitter
Issuu web publications
Order IFF materials
Order IFF Newsletter:

Instructions for players using asthma medication

Permitted Asthma medication

Salbutamol, salmeterol and formoterol are permitted in competition and out of competition in dosages considered to be appropriate for the treatment of asthma.

The use of salbutamol, provided the level in the urine is less than 1000 ng/ml (dosage guideline max. 1600 µg/24 h), salmeterol by inhalation (should be used in accordance with the manufacturers“ recommended therapeutic regime) and formoterol by inhalation (max. dose 54 micrograms (µg) over 24 hours) do not require a TUE. These substances when used in other ways, for example orally (tablets), are still prohibited and require TUE’s.

Inhaled Asthma medications that include salbutamol are: Airomir, Atrodual, Buventol, Ipramol, Salipra, Ventilastin and Ventoline. Inhaled Asthma medications that include salmeterol are: Seretide and Serevent. Asthma medications that include formoterol are for example: Foradil, Formoterol, Innovair, Oxis and Symbicort.

Inhaled glucocorticosteroids are permitteddo not require a Therapeutic Use Exemption (TUE)-

Asthma medication requiring a TUE

Some Beta-2 agonists e.g. terbutaline is prohibited and require a Therapeutic Use Exemption (TUE). The request for a TUE should include a complete medical file with a clear explanation of why an alternate medication is being prescribed.

Summary of requirements for the medical file in case of asthma (attach to TUE application):

  1. A complete medical history
  2. A comprehensive report of the clinical examinations with specific focus on the respiratory system
  3. A report of spirometry with the measure of the Forced Expiratory Volume in 1 second (FEV1)
  4. If airway obstruction is present, the spirometry will be repeated after inhalation of a short acting Beta-2 agonist to demonstrate the reversibility of bronchocontriction
  5. In the absence of reversible airway obstruction, a bronchial provocation test is required to establish the presence of airway-hyper responsiveness

Examples of Beta-2 agonists including terbutaline: Bricanyl and Terbasmin.
Floorball Videos

Events

ADAMS